- Home
- COLL vs SAFE Comparison
COLL vs SAFE Comparison
Compare COLL & SAFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLL
- SAFE
- Stock Information
- Founded
- COLL 2002
- SAFE 2016
- Country
- COLL United States
- SAFE United States
- Employees
- COLL N/A
- SAFE N/A
- Industry
- COLL Biotechnology: Pharmaceutical Preparations
- SAFE Real Estate Investment Trusts
- Sector
- COLL Health Care
- SAFE Real Estate
- Exchange
- COLL Nasdaq
- SAFE Nasdaq
- Market Cap
- COLL 958.8M
- SAFE 1.1B
- IPO Year
- COLL 2015
- SAFE 2017
- Fundamental
- Price
- COLL $32.38
- SAFE $15.48
- Analyst Decision
- COLL Strong Buy
- SAFE Buy
- Analyst Count
- COLL 4
- SAFE 9
- Target Price
- COLL $43.75
- SAFE $22.33
- AVG Volume (30 Days)
- COLL 306.9K
- SAFE 391.0K
- Earning Date
- COLL 08-07-2025
- SAFE 07-28-2025
- Dividend Yield
- COLL N/A
- SAFE 4.62%
- EPS Growth
- COLL N/A
- SAFE N/A
- EPS
- COLL 1.25
- SAFE 1.46
- Revenue
- COLL $664,283,000.00
- SAFE $391,206,000.00
- Revenue This Year
- COLL $20.04
- SAFE $0.35
- Revenue Next Year
- COLL $3.98
- SAFE $4.85
- P/E Ratio
- COLL $25.16
- SAFE $10.50
- Revenue Growth
- COLL 17.17
- SAFE 2.64
- 52 Week Low
- COLL $23.23
- SAFE $13.68
- 52 Week High
- COLL $42.29
- SAFE $28.80
- Technical
- Relative Strength Index (RSI)
- COLL 71.18
- SAFE 49.30
- Support Level
- COLL $30.60
- SAFE $15.08
- Resistance Level
- COLL $31.99
- SAFE $16.09
- Average True Range (ATR)
- COLL 0.80
- SAFE 0.47
- MACD
- COLL 0.17
- SAFE -0.02
- Stochastic Oscillator
- COLL 95.50
- SAFE 40.35
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About SAFE Safehold Inc. New
Safehold Inc is a REIT that operates its business by acquiring, managing, and capitalizing ground leases. Ground leases are long-term contracts between the landlord (the Company) and a tenant or leaseholder. Ground leases generally represent ownership of the land underlying commercial real estate projects that are net leased by the fee owner of the land to the owners/operators of the real estate projects built thereon.